Treanda Treats Rare Cancer (HealthDay)

[riky]

Treanda Treats Rare Cancer
    (HealthDay)

 


HealthDay - THURSDAY, March 20 (HealthDay News) -- The Cephalon drug Treanda
(bendamustine hydrochloride) has been approved by the U.S. Food and Drug
Administration to treat chronic lymphocytic leukemia, a rare cancer that
affects the blood and bone marrow.


You are not allowed to view links. Register or Login/news.yahoo.com/s/hsn/20080320/hl_hsn/treandatreatsrarecancer